Form Bio and Ginkgo Bioworks collaborate to revolutionize AAV gene therapy development
Form Bio and Ginkgo Bioworkshave joined forces in what they call a groundbreaking partnership aimed at advancing AAV gene therapy design and development.
Archives for March 5, 2024
Epsilogen and Lonza achieve manufacturing milestone with ovarian cancer therapy
Epsilogen and Lonza have successfully completed Good Manufacturing Practice (GMP) of MOv18, an IgE antibody targeting ovarian cancer.
Terumo BCT unveils new guidance for pregnant women with sickle cell disease
Terumo Blood and Cell Technologies is working to improve treatment for pregnant sickle cell sufferers, publishing first-of-its-kind international consensus recommendations for these patients.
Neurogene expands gene therapy clinical trial for Rett syndrome treatment
Neurogene, a clinical-stage company developing genetic medicines, is expanding its ongoing phase 1/2 clinical trial investigating NGN-401 as a treatment for female pediatric patients with Rett Syndrome.